Clinical Trial Update: Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of lenabasum in dermatomyositis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis

Drugs mentioned

• lenabasum (lenabasum)

Snippet

Sponsor: Corbus Pharmaceuticals Inc. | Conditions: Dermatomyositis | Phase 3 | Status: COMPLETED